tiprankstipranks

Arthur Kirsch Insider Profile

11 Followers
Arthur Kirsch, Director at Aralez Pharmaceuticals, holds 52.36K shares in Liquidia Technologies (Ticker: LQDA), holds 0.00 shares in Kadmon Holdings (Ticker: KDMN), holds 276.61K shares in Aralez Pharmaceuticals (Ticker: ARLZQ).
tipranks
Arthur Kirsch

Arthur Kirsch
Aralez Pharmaceuticals (ARLZQ)
Director

Ranked #89,452 out of 98,042 Corporate Insiders

Profitable Transactions

27%
3 out of 11 Profitable Transactions

Average Return

-26.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$580K
100.00%
A breakdown of Arthur Kirsch's holdings

Insider Roles

Liquidia Technologies
(LQDA)
Director
Roles that Arthur Kirsch holds in companies

Most Profitable Insider Trade

Stock:
Aralez Pharmaceuticals
(ARLZQ)
Rating:Informative Sell
Date:May 27, 2014 - May 27, 2015
Return:+22.40%
The most profitable trade made by Arthur Kirsch

Arthur Kirsch's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARLZQ
Aralez Pharmaceuticals
Dec 12, 2017
Informative Buy
73.50K
$553.22
Liquidia Technologies
Jun 24, 2024
Director
Uninformative Buy
$580.14K
KDMN
Kadmon Holdings
Nov 09, 2021
Uninformative Sell
285.00K
$0.00
IMMU
Immunomedics
$0.00
List of latest transactions for each holding click on a transaction to see Arthur Kirsch's performance on stock

Arthur Kirsch insider profile FAQ

What is the percentage of profitable transactions made by Arthur Kirsch?
The percentage of profitable transactions made by Arthur Kirsch is 27%.
    What is the average return per transaction made by Arthur Kirsch?
    The average return per transaction made by Arthur Kirsch is -26.10%.
      What stocks does Arthur Kirsch hold?
      Arthur Kirsch holds: ARLZQ, LQDA, KDMN, IMMU stocks.
        What was Arthur Kirsch’s latest transaction?
        Arthur Kirsch latest transaction was an Uninformative Buy of ―.
          What was Arthur Kirsch's most profitable transaction?
          Arthur Kirsch’s most profitable transaction was an Informative Sell of ARLZQ stock on May 27, 2014. The return on the trade was 22.40%.
            What is Arthur Kirsch's role in Aralez Pharmaceuticals?
            Arthur Kirsch's role in Aralez Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.